Eve review
Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
Eve earns a Match Score of 57/100 (grade C) and sits #345 of 497 on our board under the balanced default weighting.
- Semaglutide
- $195/mo (compounded)
- Tirzepatide
- $195/mo (compounded)
- Coverage
- Coverage not published
- Brand-name
- Yes
- Oral option
- Yes
- Verification
- LegitScript-certified
Best for: People who want women's-health GLP-1 with compounded or brand-name access.
MatchScript's take: Our #345 pick of 497 — one of the few with a non-injection route, scored on the same six factors as everyone else.
The factor breakdown
Eve on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $195/mo (compounded) puts Budget Fit at a below-par 54 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
Eve adds an oral/sublingual route and brand-name access on top of injectables, for a strong 90 on Formulary Match.
Support lands at a below-par 71 — lighter, meds-first support.
Flexibility scores a below-par 41 — fewer levers to flex your plan.
LegitScript certification and clear public disclosures give a below-par 28 on Transparency.
Pricing in context
How Eve's monthly price sits against the category median and the cheapest provider we track.
What we like
- Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
- Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- Oral sublingual semaglutide offered alongside injectable
The caveats
- Full states-served list not disclosed publicly
- 503A pharmacy partner not named, and 503A vs 503B status not specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law / arbitration venue not stated
Who it's for — and who should skip it
Choose Eve if people who want women's-health GLP-1 with compounded or brand-name access.
Skip it if that doesn't sound like you. A closer fit may be Bioverse (Match Score 57) — or take the quiz to see where Eve lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Eve against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Evethis provider | CoreAge Rxour #1 | Bioverseclosest scorer |
|---|---|---|---|
| Sema price | $195/mo (compounded) | $149/mo | $129/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + oral + brand | Injectable | Injectable + brand |
| Match Score | 57 · C | 91 · A− | 57 · C |
Eve, answered
Is Eve legit?
Yes — Eve is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved; confirm your prescriber is US-licensed at intake.
How much does Eve cost?
Eve lists compounded semaglutide from $195/mo (compounded) and tirzepatide from $195/mo (compounded) — above our category median of $179/mo. These are the provider's public figures at our last review (June 2026); confirm on their site, since some teaser tiers step up after month one.
Does Eve ship to my state?
Eve operates in a limited set of states (Coverage not published). If yours isn't on that list, you'll need a nationwide provider instead.
Eve vs CoreAge Rx — which is better?
Both are on our board. Eve scores 57/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. Eve can still win for you if its strengths match your priorities — best for: People who want women's-health GLP-1 with compounded or brand-name access. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified June 2026 from Eve's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Eve's site. Not medical advice; see our disclosure.
Eve earns a Match Score of 57/100 (grade C) and sits #345 of 497 on our board under the balanced default weighting. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual… Best for: People who want women's-health GLP-1 with compounded or brand-name access. If it isn't the right fit, Bioverse is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Eve on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Hello Alpha#346 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Heros Health#347 | 57 | $199/mo (compounded) | $199/mo (compounded) | Coverage not published | Alternatives | Visit |
| Joi + Blokes#348 | 57 | $199/mo (promotional rate, quarterly plan, compounded) | $299/mo (quarterly plan, compounded) | Coverage not published | Alternatives | Visit |
| Luma Meds#349 | 57 | $249/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| Peptivo#350 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Revive Meds#351 | 57 | $369/mo (starting dose, compounded) | $459/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Rewinding RX#352 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Rivas Medical Weight Loss#353 | 57 | Not disclosed | Not disclosed | 3 states | Alternatives | Visit |
| Roboclinic#354 | 57 | $179/mo (12-month plan, compounded) | $299/mo (12-month plan, compounded) | Coverage not published | Alternatives | Visit |
| Signos#355 | 57 | $199/mo (6-month plan, compounded) | $199/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| TeleSlim Clinic#356 | 57 | Not disclosed | Not disclosed | 6 states | Alternatives | Visit |
| Voxy#357 | 57 | $179/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| EOS Health#358 | 56 | $199/mo (compounded) | $289/mo (compounded) | 40 states | Alternatives | Visit |
| Form Health#359 | 56 | $1,350/mo (starting dose, brand-name) | $1,350/mo (starting dose, brand-name) | All 50 states | Alternatives | Visit |
| LevelUp Rx#360 | 56 | $150/mo (starting dose, compounded) | $250/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| LVNG RX#361 | 56 | $149/mo (starting dose, compounded) | $249/mo (microdose tier, starting dose, compounded) | Coverage not published | Alternatives | Visit |
| MDLive#362 | 56 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Medivive#363 | 56 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Metabolyz#364 | 56 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| QuickMD#365 | 56 | $279/mo (compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Remi Meds#366 | 56 | $249/mo (0.25 mg dose, compounded) | $349/mo (2.25 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| SkyRx#367 | 56 | $199/mo (all doses, 12-month plan, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Strive Pharmacy#368 | 56 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Vital Edge#369 | 56 | $350/mo (compounded) | $450/mo (compounded) | Coverage not published | Alternatives | Visit |